The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2

BACKGROUND/AIMS: Real-world, clinical practice data are lacking about sofosbuvir/ribavirin (SOF/RBV) treatment of Korean patients with hepatitis C virus genotype 2 (HCV GT2) infection. This study investigated the efficacy and safety of SOF/RBV in Korean patients with HCV GT2 infection and clinical f...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sung Yong, Woo, Hyun Young, Heo, Jeong, Park, Sang Gyu, Pyeon, Sung Ik, Park, Young Joo, Kim, Dong Uk, Kim, Gwang Ha, Kim, Hyung Hoi, Song, Geun Am, Cho, Mong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137398/
https://www.ncbi.nlm.nih.gov/pubmed/30879288
http://dx.doi.org/10.3904/kjim.2018.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137398/
https://www.ncbi.nlm.nih.gov/pubmed/30879288
http://dx.doi.org/10.3904/kjim.2018.329

Ejemplares similares